Observational Study of Vision Improvement in Late Stage Dry AMD Patients - Trial NCT04349254
Access comprehensive clinical trial information for NCT04349254 through Pure Global AI's free database. This phase not specified trial is sponsored by Optimal Acuity Corporation and is currently Completed. The study focuses on Dry Age-related Macular Degeneration. Target enrollment is 17 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Optimal Acuity Corporation
Timeline & Enrollment
N/A
Aug 14, 2020
Dec 31, 2020
Primary Outcome
CDVA
Summary
The purpose of this study is to assess the vision improvement achieved by patients with late
 stage dry age-related macular degeneration who received corneal treatments by a low vision
 aid device.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04349254
Device Trial